Vaccine Development

At Least 400 Vaccine Products Are In The Works

Published in Vaccine Weekly, April 11th, 2001

Despite recent reports of the potential dangers associated with certain pediatric vaccines, controversies surrounding clinical trial procedures, and conflicting patent positions, the pipeline for vaccine products is more robust than ever.

According to a new study from Theta Reports, New York, more than 15 new immunotherapy medicines have come to market in the past two years and at least 25 products are in late stage clinical trials. Furthermore, at least 400 vaccine products are in various earlier stages of development.

Therapeutic vaccines, the category that represents the vast majority of early-stage products, include antibody, gene, and...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Vaccine Weekly

Source: Vaccine Weekly (2001-04-11)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry